Litcius/Paper detail

Discovery of novel ULK1 inhibitors through machine learning-guided virtual screening and biological evaluation

Miaomiao Kong, Tao Wei, Bo Liu, Zixuan Xi, Juntao Ding, Xin Liu, Ke Li, Tianli Qin, Zhen-Yong Qian, Wencan Wu, Jian‐Zhang Wu, Wulan Li

2024Future Medicinal Chemistry6 citationsDOIOpen Access PDF

Abstract

Aim: Build a virtual screening model for ULK1 inhibitors based on artificial intelligence. Materials & methods: Build machine learning and deep learning classification models and combine molecular docking and biological evaluation to screen ULK1 inhibitors from 13 million compounds. And molecular dynamics was used to explore the binding mechanism of active compounds. Results & conclusion: Possibly due to less available training data, machine learning models significantly outperform deep learning models. Among them, the Naive Bayes model has the best performance. Through virtual screening, we obtained three inhibitors with IC50 of μM level and they all bind well to ULK1. This study provides an efficient virtual screening model and three promising compounds for the study of ULK1 inhibitors.

Topics & Concepts

Virtual screeningMachine learningArtificial intelligenceNaive Bayes classifierComputer scienceDocking (animal)ULK1Drug discoveryComputational biologyDeep learningMechanism (biology)Bayes' theoremBioinformaticsChemistryBiologySupport vector machineBiochemistryBayesian probabilityMedicineKinaseEpistemologyProtein kinase ANursingPhilosophyAMPKComputational Drug Discovery MethodsNatural product bioactivities and synthesisCytokine Signaling Pathways and Interactions
Discovery of novel ULK1 inhibitors through machine learning-guided virtual screening and biological evaluation | Litcius